INSIGHTS ON DRUG DEVELOPMENT

• Advancing Multiomics Through Intelligent Automation

  Modern automation tackles hidden pipetting errors and boosts reproducibility. Discover how your lab can scale confidently, reduce rework, and accelerate multiomic workflows with built-in traceability.

• Formulation Development For Therapeutic Oligonucleotides

  Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.

• Navigating The Regulatory Space To Biosimilar Approval

  The biosimilar patent cliff is reshaping pharma, creating unprecedented opportunities for biotech and CDMOs. Explore expert regulatory support that can help you navigate this shift with confidence.

• Faster Clones, Simpler Process: What's Changing In CHO Expression?

  This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.

• Injection Site Reaction Screening Methodology

  6/6/2025

  Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.

• Overcoming API Constraints And Tight Timelines With On-Demand Manufacturing

  3/20/2026

  Use innovative lipid-based formulations and on-demand manufacturing to accelerate Phase 1 trials, enable flexible dose escalation, and maximize limited API for poorly soluble compounds.

• Revolutionizing Drug Discovery: The Rise Of Fashionable Models

  6/6/2024

  As a result of advancements in research technology, "fashionable models" such as organoids and organs-on-chips (OoCs) have been developed. Explore organoid and OoC technologies in detail.

• Patented Process For Intermediates Useful For Etrasimod Arginine

  3/13/2026

  Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.

• Tablet Manufacturing Technologies For Solid Drug Formulation

  4/2/2025

  Compressed tablets are common oral solid dosages that contain the API and various excipients. Learn about the critical steps in selecting manufacturing methods and excipients to achieve the desired therapeutic effects and stability.